2
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Breast Neoplasms
10
Leukemia, Lymphocytic, Chronic, B-Cell
7
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Lymphoma, Mantle-Cell
6
Lymphoma, B-Cell, Marginal Zone
6
Unspecified Adult Solid Tumor, Protocol Specific
5
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
5
Lymphoma, Non-Hodgkin
5
Lymphoma, Large B-Cell, Diffuse
5
Lymphoma, Follicular
5
Colorectal Neoplasms
5
Waldenstrom Macroglobulinemia
4
Rectal Neoplasms
4
Pancreatic Neoplasms
4
Lymphoma, T-Cell, Cutaneous
4
Lymphoma, Large-Cell, Immunoblastic
4
Lymphoma, Extranodal NK-T-Cell
4
Lymphoma
4
Leukemia, Prolymphocytic
4
Leukemia, Myeloid, Acute
4
Leukemia
4
Hodgkin Disease
4
Congenital Abnormalities
4
Carcinoma, Non-Small-Cell Lung
4
Carcinoma, Hepatocellular
4
Burkitt Lymphoma
4
Squamous Cell Carcinoma of Head and Neck
3
Sezary Syndrome
3
Neoplasms
3
Mycosis Fungoides
3
Interventions
Temozolomide
15
Radiotherapy
11
Everolimus
6
Bevacizumab
6
Irinotecan
5
Cyclophosphamide
5
ribociclib
4
Radiation
4
Panobinostat
4
TIC10 compound
3
Specimen Handling
3
Re-Irradiation
3
Etoposide
3
Dasatinib
3
pembrolizumab
2
nimotuzumab
2
abemaciclib
2
Vorinostat
2
Valproic Acid
2
Topotecan
2
Nivolumab
2
Mebendazole
2
Magnetic Resonance Spectroscopy
2
Granulocyte-Macrophage Colony-Stimulating Factor
2
Gemcitabine
2
GDC-0084
2
Erlotinib Hydrochloride
2
Diphtheria-Tetanus Vaccine
2
Cilengitide
2
Cetuximab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Diffuse Intrinsic Pontine Glioma
×
Pharmacogenomic Testing
×
Clear all
NCT01165333
2026-03-16
CILENT
Centre Oscar Lambret
Phase 1
Completed
32 enrolled